Abstract: The present invention relates to a pharmaceutical formulations and compositions comprising cholinergic agonist agents such as pilocarpine-R-(+)-lipoate or its salt, solvate, or hydrate thereof for oral administration with improved compliance, safety, and bioavailability. It further discloses methods of preparing the formulations and its use for the treatment of xerostomia, dry mouth and Sjogren's syndrome.
| # | Name | Date |
|---|---|---|
| 1 | 202247062160.pdf | 2022-11-01 |
| 2 | 202247062160-STATEMENT OF UNDERTAKING (FORM 3) [01-11-2022(online)].pdf | 2022-11-01 |
| 3 | 202247062160-PROOF OF RIGHT [01-11-2022(online)].pdf | 2022-11-01 |
| 4 | 202247062160-PRIORITY DOCUMENTS [01-11-2022(online)].pdf | 2022-11-01 |
| 5 | 202247062160-POWER OF AUTHORITY [01-11-2022(online)].pdf | 2022-11-01 |
| 6 | 202247062160-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [01-11-2022(online)].pdf | 2022-11-01 |
| 7 | 202247062160-FORM FOR SMALL ENTITY(FORM-28) [01-11-2022(online)].pdf | 2022-11-01 |
| 8 | 202247062160-FORM 1 [01-11-2022(online)].pdf | 2022-11-01 |
| 9 | 202247062160-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [01-11-2022(online)].pdf | 2022-11-01 |
| 10 | 202247062160-DECLARATION OF INVENTORSHIP (FORM 5) [01-11-2022(online)].pdf | 2022-11-01 |
| 11 | 202247062160-COMPLETE SPECIFICATION [01-11-2022(online)].pdf | 2022-11-01 |
| 12 | 202247062160-Correspondence_Form-1_24-11-2022.pdf | 2022-11-24 |
| 13 | 202247062160-FORM 3 [18-02-2023(online)].pdf | 2023-02-18 |